Type
Essay
Pages
4 pages
Word Count
677 words
School
Cambridge College
Course Code
LAW 221`

Health Law

November 26, 2020
Running head: HEALTH LAW DISCUSSION 1
Health Law Discussion
Name
Institution
Instructor
Course
Date
HEALTH LAW DISCUSSION 2
Health Law Discussion
Direct to consumer marketing of pharmaceutical products (medications and procedures)
should be prohibited. Pharmaceutical companies have vigorously fought to advertise their
products directly to consumers via mass media basing their arguments on the constitutional
protection of free speech and freedom of the press. However, medical associates continuously
oppose this motive stating that that the discussion of potential medications directly to the patient
absent filtering by the physician leads to patients demanding medication that are not appropriate
in their case. Drug consumer advertising is a massive public-health experiment where a sharp
edge is needed. Drugs have many benefits but when they are indiscriminately prescribed, their
harm outweighs their benefits. Advertising delivered directly to the consumers does not present
direct information to caregivers or patients resulting in more prescriptions and less appropriate
prescribing. The American Society of Health-System Pharmacists (ASHP) policy number 1624
recognizes that banning a constitutionally protected right such as free speech and freedom of the
press negatively affects society. However, ASHP 2016 policy position established that Direct-to-
Consumer Advertising of Prescription Medications (DCTA) negatively affects patient-prescriber
relationships and evidently increases healthcare costs.
According to Kopp and Bang (2000), there is no evidence that pharmaceutical consumer
ads increase earlier provision or improves treatment care quality. Instead, these direct consumer
ads display an imbalanced picture where only emotional appeals are beneficially ignoring the

Subscribe Now

Sign up to view full document

View Document